Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I will analyze SOFI stock and the recent short report.

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
06 Apr 2026, 22:42 UTC
Recorded by Tahlil Plus
18 May 2026, 20:24 UTC
Video preview for Friends! In this video, I will analyze SOFI stock and the recent short report.
Source overview

AI-generated source summary

The stock SOFI has experienced a significant decline, but the analysis suggests a potential turnaround. The company's consistent growth in members, strong EPS growth projections, and the CEO's stock purchases indicate underlying strength. Despite short-seller reports and broader market concerns like recession, the company's financial performance and future growth potential suggest a bullish outlook. The current P/E ratio of 41 is high, but the projected EPS growth to 2030, with a forward P/E of 25, suggests substantial upside potential. However, risks related to recession and credit default rates need to be monitored.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail